EZH2 and prostate carcinoma: Consistent with the literature27,28, treating LNCaP cells with MDV3100 or culturing another AR-positive prostate cancer cell line 22Rv1 in CSS medium has resulted in induction of H3K27me3 and NE markers (Fig. 2a), which suggests that ADT activates EZH2’s PRC2 activity.